ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis

Thomas Worzfeld1, Jakub M Swiercz, Mario Looso

  • 1Max-Planck-Institute for Heart and Lung Research, Department of Pharmacology, Bad Nauheim, Germany.

Insights

Plexin-B1 activation drives metastasis in ErbB-2 positive breast cancer. Targeting Plexin-B1 may improve outcomes for patients with this aggressive cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Metastatic breast cancer has a poor prognosis, necessitating new therapeutic targets.
  • Understanding metastasis mechanisms is crucial for developing effective treatments.
  • ErbB-2 overexpression in breast cancer correlates with high metastatic potential and poor prognosis, yet downstream signaling is not fully understood.

Purpose of the Study:

  • To investigate the role of Plexin-B1 in ErbB-2-driven breast cancer metastasis.
  • To identify downstream signaling pathways mediating ErbB-2's pro-metastatic effects.

Main Methods:

  • Utilized human breast cancer cell lines overexpressing ErbB-2.
  • Examined Plexin-B1 phosphorylation and activation.
  • Assessed the impact of Plexin-B1 on small GTPase activation (RhoA, RhoC) and cell invasion.
  • Employed a mouse model of ErbB-2-overexpressing breast cancer with Plexin-B1 gene ablation.
  • Correlated Plexin-B1 expression levels with patient prognosis in ErbB-2 positive breast cancer.

Main Results:

  • ErbB-2 overexpression induced Plexin-B1 phosphorylation and activation.
  • Plexin-B1 activation was essential for ErbB-2-mediated RhoA and RhoC activation.
  • Plexin-B1 promoted invasive behavior in human breast cancer cells.
  • Ablation of Plexin-B1 significantly reduced metastasis in a mouse model.
  • Low Plexin-B1 expression in patients correlated with a favorable prognosis.

Conclusions:

  • Plexin-B1 is a key mediator of ErbB-2-driven breast cancer cell invasion and metastasis.
  • Plexin-B1 represents a potential therapeutic target for ErbB-2-positive breast cancer.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
1.8K